Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G O Skeie

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Cellular and Molecular Life Sciences : CMLS|November 25, 2000
Skeletal muscle titin: physiology and pathophysiologyG O Skeie
European Journal of Neurology|August 23, 2008
Paraneoplastic myasthenia gravis: immunological and clinical aspectsG O Skeie, F Romi
Acta Neurologica Scandinavica. Supplementum|April 28, 2006
Titin and ryanodine receptor antibodies in myasthenia gravisG O Skeie, J A Aarli, N E Gilhus
European Journal of Neurology|August 24, 1999
EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravisF E Somnier, G O Skeie, J A Aarli, et al.
Archives of Neurology|November 14, 2000
The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodiesF Romi, G O Skeie, J A Aarli, et al.
Autoimmunity|January 1, 1995
Titin antibodies in patients with late onset myasthenia gravis: clinical correlationsG O Skeie, A Mygland, J A Aarli, et al.
Acta Neurologica Scandinavica. Supplementum|April 28, 2006
Effects of myasthenia gravis patient sera on human myoblast culturesS P Luckman, G O Skeie, G Helgeland, et al.
Journal of Neurology|July 15, 2000
Muscle autoantibodies in subgroups of myasthenia gravis patientsF Romi, G O Skeie, J A Aarli, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Muscle striation antibodies in myasthenia gravis. Diagnostic and functional significanceJ A Aarli, G O Skeie, A Mygland, et al.
Autoimmunity|January 1, 1997
Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypesG O Skeie, J P Pandey, J A Aarli, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Cellular and Molecular Life Sciences : CMLS|November 25, 2000
Skeletal muscle titin: physiology and pathophysiologyG O Skeie
European Journal of Neurology|August 23, 2008
Paraneoplastic myasthenia gravis: immunological and clinical aspectsG O Skeie, F Romi
Acta Neurologica Scandinavica. Supplementum|April 28, 2006
Titin and ryanodine receptor antibodies in myasthenia gravisG O Skeie, J A Aarli, N E Gilhus
European Journal of Neurology|August 24, 1999
EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravisF E Somnier, G O Skeie, J A Aarli, et al.
Archives of Neurology|November 14, 2000
The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodiesF Romi, G O Skeie, J A Aarli, et al.
Autoimmunity|January 1, 1995
Titin antibodies in patients with late onset myasthenia gravis: clinical correlationsG O Skeie, A Mygland, J A Aarli, et al.
Acta Neurologica Scandinavica. Supplementum|April 28, 2006
Effects of myasthenia gravis patient sera on human myoblast culturesS P Luckman, G O Skeie, G Helgeland, et al.
Journal of Neurology|July 15, 2000
Muscle autoantibodies in subgroups of myasthenia gravis patientsF Romi, G O Skeie, J A Aarli, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Muscle striation antibodies in myasthenia gravis. Diagnostic and functional significanceJ A Aarli, G O Skeie, A Mygland, et al.
Autoimmunity|January 1, 1997
Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypesG O Skeie, J P Pandey, J A Aarli, et al.
Pageof 4